Parexel International Corp (PRXL)

88.00
0.01 0.01
NASDAQ : Health Care
Prev Close 87.99
Open 88.03
Day Low/High 87.99 / 88.03
52 Wk Low/High 56.00 / 76.17
Volume 466.68K
Avg Volume 1.14M
Exchange NASDAQ
Shares Outstanding 51.12M
Market Cap 4.50B
EPS 2.10
P/E Ratio 42.69
Div & Yield N.A. (N.A)

Latest News

PAREXEL International Reports Fourth Quarter And Fiscal Year 2017 Results

PAREXEL International Reports Fourth Quarter And Fiscal Year 2017 Results

PAREXEL International Corporation (NASDAQ: PRXL) ("PAREXEL" or the "Company"), a leading global biopharmaceutical services company, today reported financial results for the fourth quarter and Fiscal Year 2017, which ended...

With Hurricane Harvey, We Are in the Crosshairs of Volatility: Market Recon

With Hurricane Harvey, We Are in the Crosshairs of Volatility: Market Recon

The nation's ability to refine oil has been reduced by almost 15%.

PAREXEL International Announces Date Of Fourth Quarter And Fiscal Year 2017 Earnings Release

PAREXEL International Announces Date Of Fourth Quarter And Fiscal Year 2017 Earnings Release

PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for the Fourth Quarter and Fiscal Year 2017 on Monday, August 28, 2017, after the close of the stock market.

PAREXEL And Osaka International Cancer Institute Form Alliance To Advance Clinical Research In Japan

PAREXEL And Osaka International Cancer Institute Form Alliance To Advance Clinical Research In Japan

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, and Osaka International Cancer Institute today announced that they have formed an alliance to advance clinical...

PAREXEL International Corporation Announces $720 Million Senior Notes Offering By West Street Merger Sub, Inc.

PAREXEL International Corporation Announces $720 Million Senior Notes Offering By West Street Merger Sub, Inc.

PAREXEL International Corporation (the "Company" or "PAREXEL") (NASDAQ:PRXL) today announced that West Street Merger Sub, Inc.

Sy Pretorius, M.D., Senior Vice President And Chief Scientific Officer (Photo: Business Wire)

Sy Pretorius, M.D., Senior Vice President And Chief Scientific Officer (Photo: Business Wire)

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that Sy Pretorius, M.

EY's Greene Sees More Med Tech, CRO Deals Ahead

EY's Greene Sees More Med Tech, CRO Deals Ahead

Consolidation, improving equity prices and sufficient firepower for deals continue to fuel med tech M&A, according to EY's Jeff Greene.

PAREXEL International Stock Sees Short Interest Decrease By 58.3%

PAREXEL International Stock Sees Short Interest Decrease By 58.3%

The most recent short interest data has been released for the 06/30/2017 settlement date, which shows a 1,244,441 share decrease in total short interest for PAREXEL International Corp , to 890,573, a decrease of 58.29% since 06/15/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

PAREXEL Receives CEO Cancer Gold Standard Re-Accreditation

PAREXEL Receives CEO Cancer Gold Standard Re-Accreditation

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that the CEO Roundtable on Cancer has again named PAREXEL a CEO Cancer Gold Standard™ employer.

PAREXEL Named To The Forbes America's Best Employers List For Second Consecutive Year

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced that for the second year in a row, Forbes has named the Company to its America's "Best Employers"...

The Law Offices Of Vincent Wong Notifies Investors Of An Investigation Of PAREXEL International Corporation In Connection With The Sale Of The Company To Pamplona Capital Management, LLP

The Law Offices of Vincent Wong are investigating the Board of Directors of PAREXEL International Corporation (NASDAQ:PRXL) for possible breaches of fiduciary duty and other violations of state law in connection with the...

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of PAREXEL International Corporation And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of PAREXEL...

PAREXEL INTERNATIONAL CORPORATION SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe Investigates Sale To Pamplona Capital Management, LLP

Former United States Securities and Exchange Commission attorney Willie Briscoe is investigating potential claims against the Board of Directors of PAREXEL International Corporation ("PAREXEL") (NasdaqGS: PRXL) concerning...

INVESTOR ALERT: Levi & Korsinsky, LLP Remind Investors Of An Investigation Concerning Whether The Sale Of PAREXEL International Corporation To Pamplona Capital Management, LLP Is Fair To Shareholders

The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased PAREXEL International Corporation (NASDAQ:PRXL) stock  prior to June 20, 2017 .

Stocks Lower as Crude Oil Slides on Supply Concerns

Stocks Lower as Crude Oil Slides on Supply Concerns

Stocks are lower as crude oil plummets.

Steep Selloff Pulls Crude Into Bear Market, S&P 500 and Nasdaq Trade Lower

Steep Selloff Pulls Crude Into Bear Market, S&P 500 and Nasdaq Trade Lower

Stocks are mostly lower as crude oil plummets.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Concerning Whether The Sale Of PAREXEL International Corporation To Pamplona Capital Management, LLP Is Fair To Shareholders

The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased PAREXEL International Corporation (NASDAQ:PRXL) stock  prior to June 20, 2017 .

Stock Futures Narrowly Mixed as Oil Plunges to Fresh 2017 Low

Stock Futures Narrowly Mixed as Oil Plunges to Fresh 2017 Low

Futures mixed even as crude oil plummets.

Parexel to Be Taken Off Market by Private Equity

Parexel to Be Taken Off Market by Private Equity

Pamplona agrees to take the pharmaceutical research company off the Nasdaq for $88.10 per share in a deal valuing the company at $5 billion.

PAREXEL International Enters Definitive Agreement To Be Acquired By Pamplona Capital Management For $88.10 Per Share In Cash

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, and Pamplona Capital Management, LLP (Pamplona) today announced that they have entered into a definitive agreement...

PAREXEL Introduces Its Connected Journey™ Of Newly Integrated Data-Driven Services To Simplify Drug Development And Commercialization

As life science companies increasingly seek to gain insights from diverse data sources to make drug development more efficient and effective, PAREXEL International Corporation (NASDAQ: PRXL), a leading global...

PAREXEL's Alberto Grignolo Named Fellow By Drug Information Association (Photo: Business Wire)

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that Alberto Grignolo, Ph.

TheStreet Quant Rating: B (Buy)